Clinical trial
A Study to Assess the Safety, Tolerability, Effectiveness and Absorption of…
NCT00466635 · Genzyme, a Sanofi Company, Industry · Terminated
Key facts
| NCT number | NCT00466635 |
|---|---|
| Title | A Study to Assess the Safety, Tolerability, Effectiveness and Absorption of Exodif™ Tablets in Clostridium Difficile-associated Diarrhea |
| Official title | An Open-label Study to Assess the Safety, Efficacy and Absorption of Exodif™ (Tolevamer Potassium Sodium) Tablets in Patients With Clostridium Difficile-Associated Diarrhea |
| Lead sponsor | Genzyme, a Sanofi Company, Industry |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Enterocolitis, Pseudomembranous, Diarrhea, Clostridium Difficile |
| Intervention type | Drug |
| Interventions | GT267-004 (tolevamer potassium sodium) |
| Enrollment | 65 |
| Start date | Apr 1, 2007 |
| Completion | Aug 1, 2007 |
| First posted | Apr 27, 2007 |
| Last update posted | Mar 19, 2015 |
| Countries | United States |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: